# FDA Inspection 1331848 - Charu Aggarwal, MD, MPH, Hematology-Oncology Division - July 20, 2026

Source: https://www.keypedia.com/records/fda_inspections/charu-aggarwal-md-mph-hematology-oncology-division/4e643ccd-0331-4a12-8e04-9d76a694403b
Source feed: FDA_Inspections

> FDA Inspection 1331848 for Charu Aggarwal, MD, MPH, Hematology-Oncology Division on July 20, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1331848
- Company Name: Charu Aggarwal, MD, MPH, Hematology-Oncology Division
- Inspection Date: 2026-07-20
- Product Type: Human Drugs
- Office Name: Philadelphia District Office

## Related Documents

- [FDA Inspection 1017164 - 2017-03-28](https://www.keypedia.com/records/fda_inspections/charu-aggarwal-md-mph-hematology-oncology-division/47299dc4-c9e5-426e-b63d-33cf9ceec5b8)

Company: https://www.keypedia.com/companies/charu-aggarwal-md-mph-hematology-oncology-division/8e6529bd-6bbe-400c-a06b-816a5ff26a98

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8
